Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Antique toys from Allentown man’s extensive collection sold for way more than expected. Find ...

Editorial cartoons for the week of May 27. Remove the ads from your TribLIVE reading experience but still support the journalists who create the content with TribLIVE Ad-Free. More Cartoons ...

Sunday's editorial cartoons include a tribute to moms, the impact of tariffs on the U.S. economy, and Donald Trump playing with dolls. From our morning news briefing to a weekly Good News ...

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives. From our morning news briefing to a weekly Good News Newsletter, get the best of The Week ...

NEW YORK, May 02, 2025--(BUSINESS WIRE)--Cartesian Growth Corporation III (the "Company") announced today the pricing of its initial public offering of 24,000,000 units, upsized from 20,000,000 ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X After her husband’s death, a widow took over Emmaus car repair shop with no experience, and ...

Cartoons have been running alongside television for nearly as long as the medium has been available, with some decades like the 1980s and 1990s bringing iconic shows still called upon fondly years ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

It believes extrapolating from Cartesian’s Phase 2, Descartes-08 would likely need six additional infusions to show a similar benefit. The Uplizna study “muddies” commercial outlook for ...